HUP0100352A2 - Mycobacterium vaccaeből származó kompozíciók és eljárások ezek alkalmazására - Google Patents

Mycobacterium vaccaeből származó kompozíciók és eljárások ezek alkalmazására

Info

Publication number: HUP0100352A2
Authority: HU; Hungary
Prior art keywords: vaccae; methods; depleted; delipidated; mycobacterium vaccae
Prior art date: 1997-12-23

Application number

HU0100352A

Other languages

English (en)

Hungarian (hu)

Inventor

Ross L. Prestidge

Margot A. Skinner

Paul Tan

Elizabeth S. Visser

James Watson

Original Assignee

Genesis Research & Development Corporation Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-23

Filing date

1998-12-23

Publication date

2001-06-28

1997-12-23 Priority claimed from US08/997,080 external-priority patent/US5968524A/en

1997-12-23 Priority claimed from US08/997,362 external-priority patent/US5985287A/en

1998-06-11 Priority claimed from US09/095,855 external-priority patent/US6160093A/en

1998-12-04 Priority claimed from US09/205,426 external-priority patent/US6406704B1/en

1998-12-23 Application filed by Genesis Research & Development Corporation Limited filed Critical Genesis Research & Development Corporation Limited

2001-06-28 Publication of HUP0100352A2 publication Critical patent/HUP0100352A2/hu

Links

241000187644 Mycobacterium vaccae Species 0.000 title abstract 6
238000000034 method Methods 0.000 title abstract 4
239000000203 mixture Substances 0.000 title abstract 3
HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 abstract 2
229930186217 Glycolipid Natural products 0.000 abstract 2
239000002253 acid Substances 0.000 abstract 2
SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 abstract 1
229920000189 Arabinogalactan Polymers 0.000 abstract 1
239000001904 Arabinogalactan Substances 0.000 abstract 1
208000035473 Communicable disease Diseases 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
239000000427 antigen Substances 0.000 abstract 1
102000036639 antigens Human genes 0.000 abstract 1
108091007433 antigens Proteins 0.000 abstract 1
235000019312 arabinogalactan Nutrition 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
238000001514 detection method Methods 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000002708 enhancing effect Effects 0.000 abstract 1
239000000706 filtrate Substances 0.000 abstract 1
230000028993 immune response Effects 0.000 abstract 1
208000026278 immune system disease Diseases 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Dermatology (AREA)
Oncology (AREA)
Genetics & Genomics (AREA)
Mycology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

HU0100352A 1997-12-23 1998-12-23 Mycobacterium vaccaeből származó kompozíciók és eljárások ezek alkalmazására HUP0100352A2 (hu)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US99662497A	1997-12-23	1997-12-23
US08/997,080 US5968524A (en)	1997-12-23	1997-12-23	Methods and compounds for the treatment of immunologically-mediated psoriasis
US08/997,362 US5985287A (en)	1996-08-29	1997-12-23	Compounds and methods for treatment and diagnosis of mycobacterial infections
US09/095,855 US6160093A (en)	1996-08-29	1998-06-11	Compounds and methods for treatment and diagnosis of mycobacterial infections
US15618198A	1998-09-17	1998-09-17
US09/205,426 US6406704B1 (en)	1996-08-29	1998-12-04	Compounds and methods for treatment and diagnosis of mycobacterial infections
PCT/NZ1998/000189 WO1999032634A2 (en)	1997-12-23	1998-12-23	Compositions derived from mycobacterium vaccae and methods for their use

Publications (1)

Publication Number	Publication Date
HUP0100352A2 true HUP0100352A2 (hu)	2001-06-28

Family

ID=27557521

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU0100352A HUP0100352A2 (hu)	1997-12-23	1998-12-23	Mycobacterium vaccaeből származó kompozíciók és eljárások ezek alkalmazására

Country Status (15)

Country	Link
EP (1)	EP1044273A2 (id)
JP (1)	JP2002514385A (id)
CN (1)	CN1294632A (id)
AU (1)	AU746311B2 (id)
BR (1)	BR9814432A (id)
CA (1)	CA2315539A1 (id)
HU (1)	HUP0100352A2 (id)
ID (1)	ID26327A (id)
IL (1)	IL136821A0 (id)
MX (1)	MXPA00006168A (id)
NO (1)	NO20003261L (id)
NZ (1)	NZ505834A (id)
PL (1)	PL341697A1 (id)
TR (1)	TR200001948T2 (id)
WO (1)	WO1999032634A2 (id)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6569436B1 (en)	1998-10-05	2003-05-27	The Malaghan Institute Of Medical Research	Method of using a vaccine
JP4415200B2 (ja) *	1999-01-29	2010-02-17	大塚製薬株式会社	遅発育性抗酸菌ポリペプチド
GB9903539D0 (en)	1999-02-16	1999-04-07	Stanford Rook Ltd	Therapy using M.Vaccae
US6462669B1 (en)	1999-04-06	2002-10-08	E. P . Survivors Llc	Replaceable LED modules
US6350457B1 (en) *	1999-06-02	2002-02-26	Genesis Research & Development Corporation Limited	Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
AU784847B2 (en) *	1999-07-12	2006-07-06	Genesis Research And Development Corporation Limited	Compounds for treatment of infectious and immune system disorders and methods for their use
EP1208207A2 (de) *	1999-08-31	2002-05-29	Michael Niederweis	Verfahren zur herstellung eines kanalbildenden proteins
NZ517409A (en)	1999-08-31	2004-05-28	Novozymes As	RP-II properties with amino acid substitutions used in detergent compositions and additives
US7217554B2 (en)	1999-08-31	2007-05-15	Novozymes A/S	Proteases and variants thereof
US6361776B1 (en) *	1999-12-06	2002-03-26	Genesis Research & Development Corp. Ltd.	Compounds isolated from M. vaccae and their use in modulation of immune responses
US20030108527A1 (en) *	1999-12-28	2003-06-12	Tsukasa Seya	Maturation-promoting agent for immature dendrtic cells
AUPQ761200A0 (en) *	2000-05-19	2000-06-15	Hunter Immunology Limited	Compositions and methods for treatment of mucosal infections
US20030104012A1 (en) *	2001-05-11	2003-06-05	Corixa Corporation	Vaccines for the treatment of autoimmune disease
US20030147861A1 (en) *	2001-07-26	2003-08-07	Genesis Research And Development Corporation Limited	Compounds and methods for the modulation of immune responses
AU2002353366A1 (en) *	2001-12-10	2003-06-23	Bakulesh Mafatlal Khamar	The process of manufacturing a pharmaceutical composition useful for management of cancer
GB0303507D0 (en) *	2003-02-14	2003-03-19	Novartis Ag	Organic compounds
US10765731B2 (en) *	2014-01-09	2020-09-08	Transgene Sa	Fusion of heterooligomeric mycobacterial antigens
CN115804834B (zh) *	2021-08-10	2025-10-21	昆明医科大学	一种具有提高免疫力和抗肿瘤以及延长寿命的多肽及其应用
CN119162167B (zh) *	2024-11-21	2025-03-11	四川大学华西医院	一种分枝杆菌基因组的提取方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8919321D0 (en) *	1989-08-25	1989-10-11	Univ London	Treatment of chronic inflammatory conditions
GB9203814D0 (en) *	1992-02-21	1992-04-08	Univ London	Treatment of long term auto-immune conditions
US6284255B1 (en) *	1996-08-29	2001-09-04	Genesis Research & Development Corporation Limited	Compounds and methods for treatment and diagnosis of mycobacterial infections

1998
- 1998-12-23 NZ NZ505834A patent/NZ505834A/xx unknown
- 1998-12-23 MX MXPA00006168A patent/MXPA00006168A/es unknown
- 1998-12-23 CN CN98813781A patent/CN1294632A/zh active Pending
- 1998-12-23 TR TR2000/01948T patent/TR200001948T2/xx unknown
- 1998-12-23 JP JP2000525553A patent/JP2002514385A/ja active Pending
- 1998-12-23 IL IL13682198A patent/IL136821A0/xx unknown
- 1998-12-23 BR BR9814432-4A patent/BR9814432A/pt not_active IP Right Cessation
- 1998-12-23 EP EP98963665A patent/EP1044273A2/en not_active Withdrawn
- 1998-12-23 WO PCT/NZ1998/000189 patent/WO1999032634A2/en not_active Ceased
- 1998-12-23 CA CA002315539A patent/CA2315539A1/en not_active Abandoned
- 1998-12-23 HU HU0100352A patent/HUP0100352A2/hu unknown
- 1998-12-23 PL PL98341697A patent/PL341697A1/xx unknown
- 1998-12-23 ID IDW20001433A patent/ID26327A/id unknown
- 1998-12-23 AU AU18936/99A patent/AU746311B2/en not_active Ceased
2000
- 2000-06-22 NO NO20003261A patent/NO20003261L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ID26327A (id)	2000-12-14
IL136821A0 (en)	2001-06-14
CN1294632A (zh)	2001-05-09
AU746311B2 (en)	2002-04-18
WO1999032634A3 (en)	1999-12-02
TR200001948T2 (tr)	2001-02-21
JP2002514385A (ja)	2002-05-21
CA2315539A1 (en)	1999-07-01
BR9814432A (pt)	2000-10-10
WO1999032634A2 (en)	1999-07-01
MXPA00006168A (es)	2005-02-24
NO20003261D0 (no)	2000-06-22
NO20003261L (no)	2000-08-22
NZ505834A (en)	2002-12-20
PL341697A1 (en)	2001-04-23
EP1044273A2 (en)	2000-10-18
AU1893699A (en)	1999-07-12

Publication	Publication Date	Title
ATE314095T1 (de)	2006-01-15	Virusähnliche partikel zur induktion von autoantikörpern
WO1999032634A3 (en)	1999-12-02	Compositions derived from mycobacterium vaccae and methods for their use
MXPA01003557A (es)	2004-04-05	Secuencias genomicas de neisseria y metodos para su uso.
MXPA01011047A (es)	2003-10-14	Secuencias genomicas de neisseria y metodos para su uso.
WO1999051748A3 (en)	2000-02-03	Fusion proteins of mycobacterium tuberculosis antigens and their uses
WO2004039956A3 (en)	2009-04-16	Compositions and methods for the treatment of immune related diseases
IL130931A0 (en)	2001-01-28	Small molecules useful in the treatment of inflammatory disease
WO2004043361A3 (en)	2007-10-04	Compositions and methods for the treatment of natural killer cell related diseases
NZ532665A (en)	2005-11-25	Neisseria meningitidis antigens and compositions
WO2004096818A3 (en)	2005-04-07	Method and compositions for identifying anti-hiv therapeutic compounds
ATE464910T1 (de)	2010-05-15	Humane cd80-mutante und zusammensetzungen und methoden zu deren herstellung und verwendung
GB2355983A (en)	2001-05-09	Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class 1 molecule and an attaching means
WO1999059617A3 (en)	2000-01-13	Immunoregulator
WO2004024072A3 (en)	2006-03-16	Novel compositions and methods for the treatment of immune related diseases
WO2005030136A3 (en)	2005-06-09	Tumor vaccine
WO2004007528A3 (en)	2006-03-02	Novel compositions and methods for the generation of mhc class ii compounds by peptide exchange
DE69839943D1 (de)	2008-10-09	Verhinderung von immunreaktivität durch verarmung oder inhibition von antigen-präsentierenden zellen
WO2001040465A3 (en)	2002-03-21	Compositions and methods for the treatment of immune related diseases
EP1072607A3 (en)	2001-09-12	Purine L-nucleosides, analogs and uses therof
WO2004041192A3 (en)	2005-03-31	Panels of molecular targets differentially expressed during cd8+ t-cell priming
WO2001066740A3 (en)	2002-09-19	Compositions and methods for the treatment of immune related diseases
WO2004004649A3 (en)	2007-09-20	Compositions and methods for the treatment of immune related diseases
WO2001016319A3 (en)	2001-10-04	Compositions and methods for the treatment of immune related diseases
WO2004003153A3 (en)	2006-12-07	Live replicating spumavirus vector